Takeda Pharmaceutical Co Ltd
F:TKDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Takeda Pharmaceutical Co Ltd (TKDA) under the Base Case is EUR per share.
Compared with the current market price of 18.6 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Takeda Pharmaceutical Does
Takeda Pharmaceutical is a global drug company that researches, develops, manufactures, and sells prescription medicines. Its main products focus on areas like gastrointestinal disease, rare diseases, plasma-derived therapies, oncology, and neuroscience. It sells these medicines to hospitals, doctors, pharmacies, and health systems around the world through its own sales force and distribution partners.
- Headquarters
- Japan JP
- Employees
- 47 455
- IPO date
- May 16, 1949
Takeda Pharmaceutical has no economic moat
Patent protection shields individual Takeda medicines, but it does not keep competitors out across the whole company for the long term. Generic copies can take sales after protection ends, while rival treatments compete even with protected medicines.
Read the full moat analysis
Revenue & Expenses Breakdown
Takeda Pharmaceutical Co Ltd
Earnings Waterfall
Takeda Pharmaceutical Co Ltd
What is the Intrinsic Value of one TKDA stock?
The intrinsic value for Takeda Pharmaceutical Co Ltd (TKDA) under the Base Case is EUR.
Is TKDA stock undervalued or overvalued?
Compared with the current market price of 18.6 EUR, the stock appears .
